Radioisotope company moves forward with CDMO plans, breaking ground on new manufacturing site in Wisconsin
As the radiopharmaceutical market has been attracting a healthy amount of attention and capital, one company is looking to plant its flag in the production of radioisotopes for use in therapeutics.
NorthStar Medical Radioisotopes, a Wisconsin-based radioisotope producer, is looking to build its CDMO arm with a new production facility to make radiopharmaceuticals used to treat cancer patients.
The new CDMO wing of the company will aim to provide collaborator companies with a wider range of development and commercial services as well as progress its in-house radiopharmaceutical programs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.